Lite Strategy, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Lite Strategy, Inc. (LITS) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $100.00 thousand as of 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-09-26
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $300.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-06-30 | $100.00K 10-K · filed 2025-09-26 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $100.00K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $300.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.30M 10-K · filed 2024-09-19 |
| 2024-03-31 | $1.80M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.30M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $3.10M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.80M 10-K · filed 2023-09-26 |
| 2023-03-31 | $3.90M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.20M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $7.60M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.60M 10-K · filed 2022-09-08 |
| 2022-03-31 | $9.50M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $10.90K 10-Q/A · filed 2022-05-23 |
| 2021-09-30 | $13.00M 10-Q/A · filed 2022-05-23 |
| 2021-06-30 | $8.30M 10-K/A · filed 2022-05-23 |
| 2021-03-31 | $10.20M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.50M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $11.90M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $4.70M 10-K · filed 2020-09-09 |
| 2020-03-31 | $5.70M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $6.90M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $8.50M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.60M 10-K · filed 2019-08-28 |
| 2019-03-31 | $6.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $7.40M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $8.70M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $4.30M 10-K · filed 2018-08-30 |
| 2018-03-31 | $2.60M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $2.80M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $3.60M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.10M 10-K · filed 2017-09-05 |
| 2017-03-31 | $1.40M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.80M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $2.40M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.40M 10-K · filed 2016-09-06 |
| 2016-03-31 | $1.80M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $2.20M 10-Q · filed 2016-02-05 |
| 2015-09-30 | $2.80M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $2.30M 10-K · filed 2015-09-02 |
| 2015-03-31 | $3.60M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $4.50M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $4.70M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $3.30M 10-K · filed 2014-09-09 |
| 2014-03-31 | $2.76M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.13M 10-Q · filed 2014-02-11 |
| 2013-09-30 | $3.90M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.95M 10-K · filed 2013-09-18 |
| 2013-03-31 | $1.81M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $433.00K 10-Q · filed 2013-02-12 |
| 2012-09-30 | $537.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $373.00K 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |